Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target increased by analysts at Robert W. Baird from $20.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Robert W. Baird’s price objective points to a potential upside of 1.89% from the stock’s current price.

A number of other research firms have also recently weighed in on SBRA. Scotiabank lowered their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. UBS Group set a $25.00 price objective on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Barclays restated a “mixed” rating and set a $23.00 target price on shares of Sabra Healthcare REIT in a research report on Monday. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $22.27.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $20.61 on Monday. The firm has a market cap of $5.27 billion, a PE ratio of 79.27, a P/E/G ratio of 1.57 and a beta of 0.64. Sabra Healthcare REIT has a one year low of $17.17 and a one year high of $22.77. The firm’s fifty day moving average is $20.43 and its two-hundred day moving average is $20.16. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The business had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The business’s quarterly revenue was up 24.7% on a year-over-year basis. During the same period last year, the company posted $0.38 earnings per share. Analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of large investors have recently bought and sold shares of the stock. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Sabra Healthcare REIT by 6.8% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock worth $61,701,000 after acquiring an additional 203,226 shares during the last quarter. Principal Financial Group Inc. raised its stake in Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after purchasing an additional 4,431,897 shares during the period. Dimensional Fund Advisors LP raised its stake in Sabra Healthcare REIT by 7.8% during the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after purchasing an additional 269,793 shares during the period. Legal & General Group Plc boosted its holdings in shares of Sabra Healthcare REIT by 16.5% in the 4th quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock valued at $27,031,000 after purchasing an additional 201,667 shares during the last quarter. Finally, Lasalle Investment Management Securities LLC acquired a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at $66,938,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.